Commercial Brand vs. Compounded Testosterone: Which Medication Should I Take for TRT?

Physician-reviewed TRT education

Compounded vs. FDA-Approved Testosterone for TRT

FDA-approved and compounded testosterone are not regulatory equivalents. Compounding can meet legitimate patient-specific needs, but FDA-approved products generally provide the strongest premarket evidence and manufacturing oversight.

Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

What does “FDA-approved testosterone” mean?

FDA-approved testosterone products have gone through the agency's drug-approval process for specific indications and formulations. Approved options include injectable and topical formulations, among others. Product-specific labeling defines concentration, dosing, administration, contraindications, warnings and monitoring information.

Generic FDA-approved testosterone is also different from compounded testosterone. An approved generic must satisfy FDA requirements for approval; a compounded preparation is not an FDA-approved generic equivalent.

Learn more in our complete testosterone replacement therapy guide.

What is compounded testosterone?

Drug compounding involves combining, mixing or altering ingredients to create a medication tailored to a patient's needs. Depending on the setting, compounding may occur under section 503A of the Federal Food, Drug, and Cosmetic Act or through an FDA-registered 503B outsourcing facility.

FDA notes that compounded drugs can serve an important medical need when an FDA-approved drug is not medically appropriate for a patient. Examples can include a needed dosage form or removal of an ingredient to which a patient has an allergy.

How does oversight differ?

This is the most important distinction. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before they are marketed. State boards of pharmacy generally have primary day-to-day oversight of traditional state-licensed pharmacies that are not outsourcing facilities, while FDA-registered 503B outsourcing facilities are subject to additional federal requirements, including current good manufacturing practice requirements and risk-based FDA inspection.

FDA also warns that poor compounding practices can result in contamination or incorrect potency. Pharmacy selection therefore matters, particularly for sterile injectable medications.

Why might a clinician consider compounded testosterone?

There are legitimate situations in which customization can be useful. A patient may need a concentration that is not commercially available, a different dosage form, or removal of a specific excipient because of a documented sensitivity. A clinician may also need a formulation that allows a patient-specific dosing strategy not readily achievable with available approved products.

Customization should be tied to a clinical need rather than the assumption that “compounded” automatically means more natural, safer, stronger or more effective.

Are compounded hormones “bioidentical”?

The word bioidentical describes a hormone that is chemically identical to the hormone produced by the human body; it does not describe FDA approval or manufacturing quality. Testosterone itself can be bioidentical whether it appears in an FDA-approved product or a compounded preparation.

Therefore, “compounded” and “bioidentical” should not be treated as synonyms, and a compounded product should not be marketed as inherently safer simply because it is described as bioidentical.

What formulations are available?

FDA-approved testosterone is available in multiple formulations, including injections and topical products. Individual products have specific concentrations and administration instructions. Compounding may provide additional patient-specific concentrations or dosage forms when medically justified.

NovaGenix does not use testosterone pellets or patches as part of its standard TRT programs. For injectable options, see our comparison of testosterone cypionate vs. enanthate. For topical treatment, see our guide to testosterone gels and creams.

Does compounded testosterone work differently?

The active testosterone molecule can produce the expected androgenic effect regardless of whether the finished medication is approved or compounded. What can differ are formulation, concentration, excipients, delivery system, pharmacokinetics, consistency and the evidence supporting that particular finished product.

Patients should therefore avoid assuming that two products with “testosterone” on the label are automatically interchangeable dose-for-dose. Changes in formulation should be managed by the prescribing clinician and followed with appropriate clinical and laboratory monitoring.

Cost and insurance

FDA-approved testosterone may be covered by insurance depending on the product, diagnosis, formulary and plan requirements. Generic approved testosterone can also be relatively inexpensive for some patients. Compounded medication is commonly cash-pay and coverage varies.

Price alone should not determine the choice. The relevant comparison includes clinical suitability, formulation, pharmacy quality, convenience, monitoring and total treatment cost.

Safety and monitoring

The risks of testosterone therapy depend on the patient and treatment—not simply whether the product is commercial or compounded. Appropriate TRT starts with confirming the diagnosis and continues with monitoring tailored to the patient's age, history, formulation and risk factors.

In February 2025, FDA announced labeling changes removing cardiovascular boxed-warning language and requiring warnings about increased blood pressure. Separately, FDA requested further updates in June 2026 concerning the age-related hypogonadism limitation of use and prostate safety information. These changes do not mean TRT is risk-free. Patients should discuss the current labeling for their prescribed product and ongoing blood-pressure monitoring with their clinician.

How NovaGenix approaches the decision

NovaGenix does not treat the commercial-versus-compounded decision as a loyalty test. The goal is to select an appropriate formulation based on diagnosis, medical history, prior response, dosing needs, tolerability, fertility goals and practical considerations.

When a compounded medication is considered, patients should understand why customization is useful and where the prescription will be filled. When an FDA-approved product meets the need, its standardized labeling and approval pathway are meaningful advantages.

Frequently asked questions

Is compounded testosterone FDA-approved?

No. FDA does not approve compounded drugs or review each compounded preparation for safety, effectiveness and quality before marketing.

Is compounded testosterone illegal?

No. Drug compounding is lawful when performed under applicable federal and state requirements. The regulatory framework differs from FDA approval of a manufactured drug.

Is compounded testosterone safer than commercial testosterone?

There is no basis for saying compounded testosterone is inherently safer. FDA-approved products have undergone premarket review, while compounded products may be appropriate when a patient has a specific medical need that available approved products cannot meet.

Is brand-name testosterone better than generic testosterone?

An FDA-approved generic is not the same as a compounded drug. Approved generics must meet FDA approval requirements and are intended to provide the same clinical benefit and risks as the corresponding brand-name product.

Can a compounding pharmacy change the carrier oil or concentration?

In appropriate circumstances, customization of ingredients or concentration may be possible. Whether that is medically and legally appropriate depends on the patient-specific prescription and applicable compounding requirements.

Medical and regulatory sources

• FDA: Compounding and the FDA — Questions and Answers
• FDA: Understanding the Risks of Compounded Drugs
• FDA: Testosterone Information

This article is educational and does not replace individualized medical advice. Prescription testosterone should be selected and monitored by an appropriately licensed clinician.